CD20 monoclonal antibodies

Truxima 500 mg/50 mL (10 mg/mL) single-dose vial Images

Generic Name: rituximab

This medication has been identified as Truxima 500 mg/50 mL (10 mg/mL) single-dose vial. It is supplied by Teva Pharmaceuticals USA, Inc.

Truxima is used in the treatment of Diffuse Large B-Cell Lymphoma; Granulomatosis with Polyangiitis; Chronic Lymphocytic Leukemia; Follicular Lymphoma; Non-Hodgkin's Lymphoma and belongs to the drug class CD20 monoclonal antibodies. Risk cannot be ruled out during pregnancy. Truxima 500 mg/50 mL (10 mg/mL) single-dose vial is not a controlled substance under the Controlled Substances Act (CSA).

Images

Truxima (Rituximab [ ri-tux-i-mab ])-medicine-500 mg/50 mL (10 mg/mL) single-dose vial

Truxima
Generic Name: rituximab [ ri-tux-i-mab ]
Imprint: medicine
Strength: 500 mg/50 mL (10 mg/mL) single-dose vial
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: CD20 monoclonal antibodies
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 63459-0104
Inactive Ingredients:
Latest News
Related Drugs